Clinical studies recruiting near Beijing

Studies with at least one listed site matching this location on the public registry. Each page explains the study in plain language, with locations and study-team contacts. Clinicians: generate a printable list for your patient →

Regional or Extend LymphAdenectomy During Resection of Intrahepatic Cholangiocarcinoma
NA · China-Japan Friendship Hospital · Second Affiliated Hospital, Zhejiang University, School of M · NCT04078230 Study of ALXN1920 in Adult Participants With Primary Membranous Nephropathy (PMN)
Phase 2 · Research Site · Alexion Pharmaceuticals, Inc. · NCT07157787 Prospective Validation and Application of an Artificial Intelligence-based Model for Evaluating the Efficacy of Breast C
Phase N/A · Sanhuan Cancer Hospital, Chaoyang District, Beijing(Cancer H · Cancer Institute and Hospital, Chinese Academy of Medical Sc · NCT06649565 A Study to Learn About the Study Medicine Elranatamab Alone and With Daratumumab in People With Multiple Myeloma Who Hav
Phase 3 · Peking Union Medical College Hospital, Chinese Academy of Me · Pfizer · NCT05020236 Blinatumomab Combined With Low-dose DLI as Maintenance Therapy After Transplantation for B-ALL
Phase 1 · Chinese PLA General Hospital · Liping Dou · NCT07677878 Qishen Yiqi Dripping Pills in Treatment of Chronic Heart FailUre
Phase 3 · Xiyuan Hospital, China Academy of Chinese Medical Sciences · Tasly Pharmaceutical Group Co., Ltd · NCT07687186 A Study to Evaluate Safety, Tolerability and Efficacy of AP306 at Fixed Doses in Dialysis Participants With Hyperphospha
Phase 2 · Peking University First Hospital · R1 Therapeutics · NCT06712654 A Study to Evaluate 9MW2821 Versus Treatment of Physician's Choice for Subjects With Recurrent or Metastatic Cervical Ca
Phase 3 · Cancer Hospital Chinese Academy of Medical Sciences · Mabwell (Shanghai) Bioscience Co., Ltd. · NCT06692166 A Study of the Safety, Tolerability and Preliminary Efficacy of B2065 in Patients With Acute Ischemic Stroke.
Phase 1/Phase 2 · Beijing Tiantan Hospital, Capital Medical University · Tasly Pharmaceutical Group Co., Ltd · NCT07371624 A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract
Phase 3 · Peking University First Hospital · Eli Lilly and Company · NCT07218380 Study of JYP0015 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS
Phase 2 · Beijing Cancer Hospital · Guangzhou JOYO Pharma Co., Ltd · NCT06895031 Optimizing Neoadjuvant Treatment Regimens for Locally Advanced Esophageal Squamous Cell Carcinoma
Phase 2/Phase 3 · Peking Union Medical College Hospital · Peking Union Medical College Hospital · NCT06907602 Phase III Clinical Study of VC004 in Patients With Localized Advanced/ Metastatic Solid Tumors
Phase 3 · Cancer Hospital,Chinese Academy of Medical Sciences and Peki · Jiangsu vcare pharmaceutical technology co., LTD · NCT06658353 Comparative Study on the Effect of Diet Interventions on Weight Loss in Overweight Endometrial Cancer Patients Undergoin
NA · Peking University People's Hospital · Peking University People's Hospital · NCT07318727 Carbon Nanoparticle-Loaded Iron in the Treatment of Advanced Solid Tumor
Phase 1/Phase 2 · Peking Union Medical College Hospital · Sichuan Enray Pharmaceutical Sciences Company · NCT07433283 A Study to Evaluate the Safety and Efficacy of SCTC21C in Combination With Bortezomib, Lenalidomide and Dexamethasone in
Phase 3 · Beijing Chaoyang Hospital affiliated to Capital Medical Univ · Sinocelltech Ltd. · NCT07297329 ICI Rechallenge for Advanced NSCLC With Long-Term Response to First-Line ICI
Phase 2 · Peking Union Medical College Hospital · Peking Union Medical College Hospital · NCT06388031 This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide W
Phase 3 · Peking University First Hospital · Pfizer · NCT07028853 Oral Vitamin D Supplementation Prevent Peritoneal Dialysis-related Peritonitis
Phase 4 · Peking University First Hospital · Peking University First Hospital · NCT05860270 Study of Trastuzumab Deruxtecan Versus Standard of Care Chemotherapy for HER2-Expressing (IHC 3+/2+) Endometrial Cancer
Phase 3 · Beijing Cancer Hospital · Daiichi Sankyo · NCT07022483 Retrospective Analysis of Early Gastric Cancer Patients Based on Prospective Clinical Dataset
Phase N/A · Beijing Friendship Hospital, Capital Medical University · Beijing Friendship Hospital · NCT07747688 Echocardiography Guided TAVR (Echo TAVR)
Phase N/A · Fuwai Hospital · Pan Xiangbin · NCT07030062 Impact of Frequency-specific Subthalamic Nucleus Subregion Stimulation on Inhibitory Control in Parkinson's Disease
NA · Beijing Tiantan Hospital, Capital Medical University · Beijing Tiantan Hospital · NCT07022522 To Observe the CD7-targeted CAR-T Therapy in the Treatment of MRD Positive T-ALL/LBL Post Allo-HSCT
Phase 1 · Peking University People's Hospital · Peking University People's Hospital · NCT07280494 Evaluation of diagnostiC Capacity of eccDNAs as Biomarkers in Indetermined biLiary Stricture(ECCBILE)
Phase N/A · Peking University Third Hospital · Peking University Third Hospital · NCT06277531 A Study to Evaluate the Efficacy and Safety of Glumetinib Combined With Osimertinib Mesylate Versus Platinum-based Doubl
Phase 3 · Cancer Hospital Chinese Academy of Medical Sciences · Shanghai JMT-Bio Inc. · NCT06829459 A Study of ASKG915 in Patients With Selected Advanced Solid Tumors.
Phase 1/Phase 2 · Peking University Cancer Hospital · AskGene Pharma, Inc. · NCT05867420 Autologous CD19/BCMA Dual-Target CAR-T for Relapsed/Refractory Autoimmune Diseases
Phase 1 · Beijing GoBroad Boren Hospital · Beijing Boren Hospital · NCT07361094 A Multicenter, Non-interventional, Descriptive Study to Assess Assay Concordance of HER2 IHC Testing in Chinese Pan-tumo
Phase N/A · Research Site · AstraZeneca · NCT07404202 Indometacin With or Without Aggressive Intravenous Hydration to Prevent Pancreatitis After Pancreatic Extracorporeal Sho
NA · Peking Union Medical College Hospital · Changhai Hospital · NCT07202559

Look up another city

Look up another condition